Infection with the high risk types of human papillomaviruses (HPVs) is strongly linked to the development of cancers of the uterine cervix. Carcinogenesis depends upon the continuous expression of the viral E6 and E7 oncogenes in the affected individual. Transcription of these oncogenes is negatively regulated by, the viral E2 protein. A frequent characteristic of carcinogenic progression of HPV positive lesions is the integration of the viral DNA into the cellular genome, accompanied by the disruption of the viral E2 open reading frame. When reintroduced into HPV positive cancer cells, E2 proteins suppress cellular growth through senescence induction. E2 mediated repression of E6/E7 expression is both necessary and sufficient for this process, indicating that important senescence mediators must be inhibited by the viral oncoproteins. This proposal aims to investigate the targeting of the cellular senescence machinery by HPV oncoproteins and to uncover basic molecular relationships between HPV carcinogenesis and cellular senescence. Our studies are interfaced with an assessment of the clinical potential that E2 may have in the treatment of HPV associated lesions. Using an E2 based inducible system, we have monitored the transcriptome of HPV positive cells during an early, yet irreversibly committed senescence stage. By detecting message levels of candidate genes in HPV positive versus HPV negative cells, we will first identify senescence associated genes, which are targeted by E6 or E7. Transcriptional regulation of these genes will be investigated in response to various wild type and mutant E6 and E7 proteins. The results will i) yield insights into mechanisms of gene regulation by E6 and E7 and ii) correlate immortalizing oncogene activities with the targeting of specific senescence-associated molecules. Monitoring the regulation of candidate genes during senescence in vitro will be extended to functional studies. We will utilize RNA interference to probe the role of genes that are unregulated during senescence. Similarly, we will overexpress molecules that are repressed during senescence. Regulators of the balance between senescence and transformation as identified in these studies may represent novel drug targets and diagnostic markers for the inhibition of tumorigenesis in humans.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA102357-04
Application #
7188105
Study Section
Cancer Molecular Pathobiology Study Section (CAMP)
Program Officer
Blair, Donald G
Project Start
2004-03-01
Project End
2009-09-27
Budget Start
2007-03-08
Budget End
2009-09-27
Support Year
4
Fiscal Year
2007
Total Cost
$286,090
Indirect Cost
Name
Cincinnati Children's Hospital Medical Center
Department
Type
DUNS #
071284913
City
Cincinnati
State
OH
Country
United States
Zip Code
45229
Zhao, Xueheng; Brusadelli, Marion G; Sauter, Sharon et al. (2018) Lipidomic Profiling Links the Fanconi Anemia Pathway to Glycosphingolipid Metabolism in Head and Neck Cancer Cells. Clin Cancer Res 24:2700-2709
Khoury, Ruby; Sauter, Sharon; Butsch Kovacic, Melinda et al. (2018) Risk of Human Papillomavirus Infection in Cancer-Prone Individuals: What We Know. Viruses 10:
Smith, Eric A; Gole, Boris; Willis, Nicholas A et al. (2017) DEK is required for homologous recombination repair of DNA breaks. Sci Rep 7:44662
Romick-Rosendale, Lindsey E; Hoskins, Elizabeth E; Privette Vinnedge, Lisa M et al. (2016) Defects in the Fanconi Anemia Pathway in Head and Neck Cancer Cells Stimulate Tumor Cell Invasion through DNA-PK and Rac1 Signaling. Clin Cancer Res 22:2062-73
Chlon, Timothy M; Ruiz-Torres, Sonya; Maag, Logan et al. (2016) Overcoming Pluripotent Stem Cell Dependence on the Repair of Endogenous DNA Damage. Stem Cell Reports 6:44-54
Lombardi, Anne J; Hoskins, Elizabeth E; Foglesong, Grant D et al. (2015) Acquisition of Relative Interstrand Crosslinker Resistance and PARP Inhibitor Sensitivity in Fanconi Anemia Head and Neck Cancers. Clin Cancer Res 21:1962-72
Adams, Allie K; Wise-Draper, Trisha M; Wells, Susanne I (2014) Human papillomavirus induced transformation in cervical and head and neck cancers. Cancers (Basel) 6:1793-820
Chlon, Timothy M; Hoskins, Elizabeth E; Mayhew, Christopher N et al. (2014) High-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells. J Virol 88:11315-26
Romick-Rosendale, Lindsey E; Lui, Vivian W Y; Grandis, Jennifer R et al. (2013) The Fanconi anemia pathway: repairing the link between DNA damage and squamous cell carcinoma. Mutat Res 743-744:78-88
Hoskins, Elizabeth E; Morreale, Richard J; Werner, Stephen P et al. (2012) The fanconi anemia pathway limits human papillomavirus replication. J Virol 86:8131-8

Showing the most recent 10 out of 23 publications